The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
130 jobs Number of planned job creations
Announcement Date
31 July 2007
Employment effect (start)
Foreseen end date
31 July 2009
Description
PLIVA-Lachema, a Czech firm specializing in the production of pharmaceutical products, is to create 130 new jobs through the expansion of its Brno plant. The expansion follows the acquisition of the firm by Barr Pharmaceuticals, a U.S. group. The expansion of the Brno site will involve an investment of 500 million CZK and the development of a new line for the production of cytostatic injections for chemotherapy. The new investment will require employees with high levels of educational attainment, and the new jobs are expected to be created by August 2009.
Sources
31 July 2007: CzechInvest
Citation
Eurofound (2007), Pliva Lachema, Merger/Acquisition in Czechia, factsheet number 65749, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65749.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
